REG - GetBusy PLC - Exercise of Options and Total Voting Rights

GetbusyAnnouncement

04/08/2020 15:00

RNS Number : 1199V
  
GetBusy PLC
  
04 August 2020
  
 

4 August 2020
GetBusy plc
("GetBusy" or the "Company" or the "Group")
Exercise of Options and Total Voting Rights
GetBusy plc (AIM: GETB), a leading developer of document management and productivity software products, announces that it has issued a total of 525,572 new ordinary shares of 0.15 pence each following exercises of options, held pursuant to the Company's Long Term Incentive Plan, by certain current and former employees of the Company (the "New Shares").
Application will be made to the London Stock Exchange for admission of the New Shares to trading on AIM, with dealings expected to commence on 10 August 2020 ("Admission"). Following Admission, the Company will have a total of 49,425,572 ordinary shares of 0.15 pence each in issue. The Company is not holding any ordinary shares in treasury.  This figure of 49,425,572 may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest, or a change to their interest, in the issued share capital of the Company.
Enquiries




  GetBusy plc


 




  Daniel Rabie (Chief Executive Officer)


investors@getbusy.com




  Paul Haworth (Chief Financial Officer)


 




 


 




  Liberum (Nomad and Broker)


 




  Bidhi Bhoma / Cameron Duncan / Lauren Kettle


+44 (0)20 3100 2000




 
About GetBusy
GetBusy is a global Document Management and Productivity Software business that provides highly secure forms of digital document distribution, workflows and client chat. 1.9 million users are now registered to share information through GetBusy's award-winning online client portals.
Further information on the Group is available at www.getbusy.com/about/investors


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
ALSFLFEVTVISIII